257 related articles for article (PubMed ID: 19329653)
1. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Umar A; Kang H; Timmermans AM; Look MP; Meijer-van Gelder ME; den Bakker MA; Jaitly N; Martens JW; Luider TM; Foekens JA; Pasa-Tolić L
Mol Cell Proteomics; 2009 Jun; 8(6):1278-94. PubMed ID: 19329653
[TBL] [Abstract][Full Text] [Related]
2. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
De Marchi T; Liu NQ; Stingl C; Timmermans MA; Smid M; Look MP; Tjoa M; Braakman RB; Opdam M; Linn SC; Sweep FC; Span PN; Kliffen M; Luider TM; Foekens JA; Martens JW; Umar A
Mol Oncol; 2016 Jan; 10(1):24-39. PubMed ID: 26285647
[TBL] [Abstract][Full Text] [Related]
3. Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
De Marchi T; Kuhn E; Dekker LJ; Stingl C; Braakman RB; Opdam M; Linn SC; Sweep FC; Span PN; Luider TM; Foekens JA; Martens JW; Carr SA; Umar A
J Proteome Res; 2016 Apr; 15(4):1230-42. PubMed ID: 26958999
[TBL] [Abstract][Full Text] [Related]
4. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue.
Liu NQ; Braakman RB; Stingl C; Luider TM; Martens JW; Foekens JA; Umar A
J Mammary Gland Biol Neoplasia; 2012 Jun; 17(2):155-64. PubMed ID: 22644111
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance.
Besada V; Diaz M; Becker M; Ramos Y; Castellanos-Serra L; Fichtner I
Proteomics; 2006 Feb; 6(3):1038-48. PubMed ID: 16385476
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
[TBL] [Abstract][Full Text] [Related]
7. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
8. Plasma proteomics analysis of tamoxifen resistance in breast cancer.
Majidzadeh-A K; Gharechahi J
Med Oncol; 2013 Dec; 30(4):753. PubMed ID: 24158757
[TBL] [Abstract][Full Text] [Related]
9. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
Baker H; Patel V; Molinolo AA; Shillitoe EJ; Ensley JF; Yoo GH; Meneses-García A; Myers JN; El-Naggar AK; Gutkind JS; Hancock WS
Oral Oncol; 2005 Feb; 41(2):183-99. PubMed ID: 15695121
[TBL] [Abstract][Full Text] [Related]
10. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.
Yang T; Xu F; Xu J; Fang D; Yu Y; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():18-24. PubMed ID: 23968647
[TBL] [Abstract][Full Text] [Related]
11. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling.
Zang L; Palmer Toy D; Hancock WS; Sgroi DC; Karger BL
J Proteome Res; 2004; 3(3):604-12. PubMed ID: 15253443
[TBL] [Abstract][Full Text] [Related]
13. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
[TBL] [Abstract][Full Text] [Related]
14. p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer.
Berns EM; Klijn JG; van Putten WL; de Witte HH; Look MP; Meijer-van Gelder ME; Willman K; Portengen H; Benraad TJ; Foekens JA
J Clin Oncol; 1998 Jan; 16(1):121-7. PubMed ID: 9440732
[TBL] [Abstract][Full Text] [Related]
15. Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and nanoLC-MS/MS coupled with laser capture microdissection.
Zhang Z; Li M; Zhang G; Fang P; Yao H; Xiao Z; Chen Z
Med Oncol; 2010 Jun; 27(2):296-303. PubMed ID: 19330469
[TBL] [Abstract][Full Text] [Related]
16. Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides.
Schober Y; Schramm T; Spengler B; Römpp A
Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2475-83. PubMed ID: 21818808
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
18. NanoLC-FT-ICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells.
Umar A; Luider TM; Foekens JA; Pasa-Tolić L
Proteomics; 2007 Jan; 7(2):323-9. PubMed ID: 17163580
[TBL] [Abstract][Full Text] [Related]
19. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
Zhang D; Tai LK; Wong LL; Chiu LL; Sethi SK; Koay ES
Mol Cell Proteomics; 2005 Nov; 4(11):1686-96. PubMed ID: 16048908
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
